Marvel BiosciencesMRVL 
$0.094.17%24h
4.17%24h
Global rank35126
Market cap$3.65M
Change 7d0.00%
YTD Performance47.06%
SP500 benchmarkOutperform
P/E-1.53
P/S0
Revenue$0
Earnings-$1.69M
Dividend yield-
Main Sector
Healthcare
Category
EPS for Marvel Biosciences (MRVL)
Marvel Biosciences has an EPS of $-0.06. In 2022, the company made an earnings per share (EPS) of $-0.08. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for MRVL
-
Value:-
EPS history for Marvel Biosciences from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$0.06 | -25.00% |
| 2022 | -$0.08 | -52.94% |
| 2021 | -$0.17 | 479.67% |
| 2020 | -$0.029327 | - |
View the highest EPS stocks
